RedCrow Backed MindChild Successfully Receives FDA Approval

RedCrow, the innovative equity crowdfunding platform encouraging accredited and non-accredited investors initially helping health care and medtech startups grow, announced that MindChild Medical successfully received FDA approval for a non-invasive fetal heart monitor. The RedCrow-backed company submitted a 510(k) in 2012 for its MERIDIAN M110 monitor, a medical marvel measuring and displaying fetal heart rate (FHR), […]

RedCrow, the innovative equity crowdfunding platform encouraging accredited and non-accredited investors initially helping health care and medtech startups grow, announced that MindChild Medical successfully received FDA approval for a non-invasive fetal heart monitor. The RedCrow-backed company submitted a 510(k) in 2012 for its MERIDIAN M110 monitor, a medical marvel measuring and displaying fetal heart rate (FHR), maternal heart rate (MHR), and uterine contractions (UA). The device, which has the potential to save thousands of lives, is one of projects RedCrow has helped support, and further, enabled others to help support.

MindChild, a privately funded medical device company launched in 2008, inspired the founding of RedCrow. CEO and founder of RedCrow, Brian Smith, became immersed with the development of MindChild following a personal tragedy that he and his wife experienced in 2003, when their first child was born prematurely and passed away shortly after birth. While working as a financial advisor at Morgan Stanley, Smith discovered that MindChild had the capabilities to save lives like his daughter’s with their breakthrough fetal monitor. It then became evident to Brian that there was a treasure chest of other startups that could do the same and he wanted to help generate awareness for these companies while simultaneously helping them raise funds. The idea blossomed into what is now RedCrow, and after a meeting of the minds with Chairman Jerry Harrison, they carefully vetted their first portfolio of companies, focused purely on improving lives, MiRTLE MedicalIXCELA and Stretch, officially launching RedCrow in November 2016.

“We are ecstatic MindChild’s fetal heart monitor received FDA approval. It was several years in the making but it’s a massive achievement for MindChild, and for RedCrow. We now have proven ability to facilitate significant governmental approval for groundbreaking products in the medtech and healthcare sectors, paving the way for other featured companies on our platform to reach their full potential,” said Brian Smith, CEO of RedCrow.

“Being involved with MindChild from infancy to present-day is extremely rewarding. I am grateful to have been a small part of their growth and I know that others who have experienced tragedies like my own are equally as proud,” Smith continued.

Bill Edelman, CEO of MindChild stated, “We are thrilled to have reached this milestone. The MERIDIAN M110 Fetal Monitoring System is the latest in a series of non-invasive fetal monitor technologies developed by MindChild that are intended to provide the healthcare community enhanced monitoring capabilities for both fetal heart rate, maternal heart rate and uterine contraction, with a single set of disposable abdominal surface electrodes. The MERIDIAN M110 has the potential to provide essential fetal monitoring, replacing four separate monitoring technologies now in use world-wide. We anticipate significant clinical interest for this innovative technology in the markets where MERIDIAN will be cleared for commercial distribution.”

“We have initially focused on the healthcare and medtech verticals for RedCrow because that’s what we truly care about, and there is so much innovation in this space that deserves attention, and subsequent funding. Our mission at RedCrow is to discover and help investors discover privately held, early stage startups that seek to make a positive social impact. At the end of the day, if we are vetting companies that have the potential to save many lives, like MindChild, we have done our job well,” Smith said.

The MERIDIAN M110 Fetal Monitoring System can be used on women who are either in labor or who are at the minimum of 37 completed weeks. The monitor is also indicated for use with singleton pregnancies using surface electrodes on the maternal abdomen. The MERIDIAN M110 Fetal Monitoring System is intended for use by health care professionals in a clinical setting.

Read this next

Digital Assets

Embarking on a Digital Currency Journey

Imagine you’ve stumbled upon a treasure map, leading you to untold riches hidden in the vastness of the internet. Instead of gold coins and jewel-encrusted goblets, this treasure comes in the form of digital currencies, the modern-day loot coveted by many.

Reviews

Traders Union Experts Share The Trading Analyst Review For 2024

Navigating options trading in rapidly shifting markets poses a considerable challenge. This is where options trading alert services become invaluable. They aid traders in keeping abreast of evolving opportunities and market trends. In this assessment, Traders Union experts scrutinize The Trading Analyst alert service to ascertain its efficacy. 

Digital Assets

BlockDAG’s Presale Achieves $9.9M: Aiming For A 5000-Fold ROI As Cardano’s Price Rises And Fantom Launches Sonic

Explore Cardano’s surge, Sonic’s efficiency, and why BlockDAG’s growth makes it the top crypto choice. A deep dive into the future of blockchain investments.

Digital Assets

US, UK probe $20 billion Tether transfers tied to Russian exchange.

U.S. and UK authorities are investigating the movement of $20 billion in the USD-pegged stablecoin tether (USDT) through Moscow-based exchange Garantex.

Digital Assets

BlockDAG Presale Raises $9.9M as Batch 5 Nears Sell-Out Amid Bonk’s Fluctuating Trading Volume & Spell’s Bullish Price

Explore BONK’s trading volume, SPELL’s market shifts, and why BlockDAG’s 10,000 ROI makes it an ideal crypto for savvy investors in 2024.

Digital Assets

Bybit expands into Europe amid regulatory scrutiny

Dubai-based cryptocurrency exchange Bybit is expanding its operations in Europe after encountering regulatory challenges in Hong Kong.

Digital Assets

Cathie Wood’s sponsored Bitcoin ETF sees historic $200 million inflows

The ARK 21Shares Bitcoin ETF (ARKB), co-sponsored by Cathie Wood’s ARK Invest, registered historic inflows exceeding $200 million on Wednesday, signaling a robust appetite among investors for Bitcoin-centric investments.

Digital Assets

Sam Bankman-Fried might see his 25-year sentence halved

Sam Bankman-Fried, the founder of the failed cryptocurrency exchange FTX, was sentenced to 25 years in federal prison by a Manhattan court on Thursday. This comes after he was convicted of defrauding customers and investors, with Judge Lewis Kaplan highlighting the potential future risks posed by Bankman-Fried.

Technical Analysis

EURJPY Technical Analysis Report 28 March, 2024

EURJPY currency pair under the bearish pressure after the pair reversed down from the major resistance level 164.25, which also stopped the sharp weekly uptrend at the end of last year,

<